Clínica Baviera, S.A. (BME:CBAV)

Market Cap	540.35M
Revenue (ttm)	252.47M
Net Income (ttm)	37.07M
Shares Out	15.99M
EPS (ttm)	2.32
PE Ratio	14.57
Forward PE	n/a
Dividend	1.57 (4.60%)
Ex-Dividend Date	Jul 16, 2024

Volume	1,504
Average Volume	1,654
Open	34.10
Previous Close	34.10
Day's Range	33.60 - 34.10
52-Week Range	23.60 - 39.50
Beta	0.69
RSI	48.52
Earnings Date	Feb 25, 2025

About Clínica Baviera

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, and vías lagrimales treatments. The company is based in Madrid, Spain. Clínica Baviera, S.A. is a subsidiary of Aier Eye International (Europe), S.L.U.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1992
• Employees: 1,254
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: CBAV

Financial Performance

In 2023, Clínica Baviera's revenue was 227.07 million, an increase of 14.42% compared to the previous year's 198.45 million. Earnings were 35.97 million, an increase of 21.86%.